ChemDiv, Inc. Enters Into Research and Collaboration Agreement With Janssen Pharmaceutica N.V. and Tibotec Pharmaceuticals Ltd
12/20/2011 8:47:00 AM
More...
|
Bristol-Myers Squibb Company (BMY) Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals Ltd for Phase II Combination Study in Patients Chronically Infected with Hepatitis C
12/2/2011 7:37:10 AM
More...
|
Gilead Sciences, Inc. (GILD) Finalizes Agreement with Tibotec Pharmaceuticals Ltd to Develop and Commercialize a Single-Tablet Regimen of Prezista® with Emtriva®, GS 7340 and Cobicistat
11/16/2011 10:31:41 AM
More...
|
Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ)'s Tibotec Pharmaceuticals Ltd to Create Combination HIV Therapy
11/16/2011 6:14:56 AM
More...
|
Tibotec Pharmaceuticals Ltd to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at American Association for Study of Liver Diseases
11/7/2011 10:53:58 AM
More...
|
Tibotec Pharmaceuticals Ltd's EDURANT(R) (rilpivirine) Receives Positive Opinion from CHMP for Use in Treatment-Naive Adults with HIV-1
9/23/2011 8:31:40 AM
More...
|
Pharmasset, Inc. (VRUS) Enters into a Clinical Collaboration Agreement with Tibotec Pharmaceuticals Ltd for a Combination Study in Patients Chronically Infected with Hepatitis C
7/6/2011 8:15:14 AM
More...
|
Tibotec Pharmaceuticals Ltd Signs Multiple Agreements With Generic Manufacturers, Including Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO), Aspen Pharmacare Holdings and Hetero Drugs to Provide Access to New HIV Treatment
1/27/2011 8:00:52 AM
More...
|
Tibotec Pharmaceuticals Ltd Submits New Drug Application for Investigational Once-Daily HIV Treatment TMC278 to U.S. FDA
7/26/2010 10:48:27 AM
More...
|
Tibotec Pharmaceuticals Ltd Announces TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective
7/22/2010 7:06:58 AM
More...
|
|